Exelixis to fire 270 workers Bizjournals.com XL-184 is in Phase III for medullary thyroid cancer, Phase II for recurrent brain cancer glioblastoma, Phase Ib/II for non-small cell lung cancer and Phase ...
OSI Bid Likely to Rise as Astellas Seeks Cancer Sales Bloomberg Tarceva won US clearance in November 2004 for non-small cell lung cancer, and a year later for pancreatic cancer. It's approved for patients who stop ...
PARD - Poniard Pharmaceuticals Looking for Approval/Partners World Market Media (blog) ... a cancer fighting drug known as Picoplatin, which is in phase 2 for prostate cancer and colorectal cancer; and phase three for small cell lung cancer. ...
Oncolytics Biotech(R) Inc. Announces 2009 Year End Results Earthtimes (press release) These indications are expected to include melanoma, pancreatic cancer, squamous cell lung, liver and Kras mutated colorectal cancers in combination with ...
Oncolytics Biotech(R) Inc. Announces 2009 Year End Results Article Ant (press release) These indications are expected to include melanoma, pancreatic cancer, squamous cell lung, liver and Kras mutated colorectal cancers in combination with ...
